FDA Approves mFlusiva: The First mRNA Flu Vaccine for Adults 50 and Older
FDA Approves mFlusiva, the First mRNA Flu Vaccine, for Adults 50 and Older The United States Food and Drug Administration (FDA) has approved mFlusiva (mRNA-1010),...
8 articles
FDA Approves mFlusiva, the First mRNA Flu Vaccine, for Adults 50 and Older The United States Food and Drug Administration (FDA) has approved mFlusiva (mRNA-1010),...
The United States is in the middle of its worst measles outbreak in decades, with confirmed cases surpassing 2,900 in 2026 — and health officials...
The United States measles outbreak of 2026 has become the nation’s worst in more than three decades, with the CDC now reporting 2,777 confirmed measles...
The United States is facing its worst measles year in more than three decades. According to the latest data from the U.S. Centers for Disease...
Measles Cases Surge Across 41 States as CDC Warns of Further Spread The United States is facing its most severe measles outbreak in over a...
Landmark Study: HPV Vaccine Virtually Eliminates Cervical Cancer Deaths in Young Women A groundbreaking new study published in The Lancet has revealed that the HPV...
US Measles Crisis Deepens: Over 2,000 Cases for Second Consecutive Year The United States is facing a deepening measles crisis as the nation records more...
Michelle Goveia, MD, Executive Director, Global Medical and Scientific Affairs at Merck Vaccines and Dr. Learn more on Health Professional Radio.